Background
Up to 1.7 million Healthcare Associated Infections (HAIs) occur in US hospitals each year. HAIs are responsible for approximately 100,000 deaths and costs of up to $45 billion. [1] [2] [3] Chlorhexidine gluconate solution is a broad-spectrum antimicrobial that has been used routinely for skin antisepsis prior to surgical procedures and intravascular catheter insertion. [4] [5] Chlorhexidine solution can also be used for daily bathing of critical care patients. Its use is associated with decreases in infections, caused by organisms such as methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE).
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Objectives
The aim of this study was to evaluate the effectiveness of bed bathing patients with 4% chlorhexidine gluconate solution (Hibiclens ® ) in preventing healthcare-associated infections (HAIs).
Design
This was a quasi-experimental, dose-ranging, staged-introduction study involving three inpatient cohorts. Initially, chlorhexidine bathing was performed on three days per week. After six months, chlorhexidine bathing was carried out every day. The every-day bathing period continued for up to 13 months. After a 19-month intervention period, there was a four-month washout period during which time chlorhexidine bathing was halted.
Key Points
l Regular bathing of hospitalized patients with Hibiclens 4% chlorhexidine gluconate solution was associated with significant reductions in Clostridium difficile infections (CDI).
l The incidence of C. difficile infections increased once chlorhexidine bathing was halted.
l Chlorhexidine solution was not associated with any adverse events.
Clinical Summary Clinical Summary
Conclusion
Daily patient bathing with chlorhexidine gluconate is an attractive horizontal infection prevention intervention that may have beneficial effects on a number of HAIs. Chlorhexidine gluconate bathing was associated with a reduction in C. difficile infection rate in this hospital-wide study. This protocol was well tolerated and there were no reports of adverse events associated with the 4% chlorhexidine solution.
